1. Home
  2. >>Analysis
  3. >>Partnered Content

Podcast – the state of the pharmacy market in 2023

 
• By Nana Ofori-Atta
sponsored
The podcast covers market trends in the community pharmacy sector

It follows the publication of Christie & Co’s annual market review last month, in which it was revealed that the average UK locum rate rose by 4.1% to £38.44 per hour between June 2022 and July 2023.

Read more: ‘Popular’ Glasgow pharmacy changes hands for first time since 1987

Mr Ofori-Atta was joined by Tony Evans, head of pharmacy at Christie & Co, as well as director Karl Clezy and Shaun Watts, head of unsecured at Christie Finance, UK-wide. You can listen to the podcast below.

Listen to the podcast to find out:

  • Recent changes in the pharmacy market and what this means for buyers
  • The effect of rising locum rates on the sector
  • Market trends and how these could affect contractors and employee pharmacists alike.

Chemist + Druggist pharmacy podcast · Market Review 2023 with Christie & Co

Open Media

You can listen to the podcast above. Alternatively, follow C+D’s podcasts by searching “Chemist+Druggist podcast” on your preferred app or on Soundcloud

You can read Christie & Co’s full pharmacy market review 2023 here

More from Partnered Content

Running a medical cannabis service in your pharmacy

 
• By Saša Janković
 • comment

Saša Janković talks to community pharmacist Dane Stratton-Powell about partnering with Curaleaf Laboratories to offer a medical cannabis service to his patients.

Roundtable to explore the impact of the delay in Hub and Spoke legislation - summary

 • comment

This roundtable discussion explored how Hub and Spoke could offer some relief to the pressures facing community pharmacy.

Hub and Spoke: an unhealthy delay to a lifeline for pharmacy

 
• By Saša Janković
 • comment

Changes to allow community pharmacies to reap the benefits from Hub and Spoke have been delayed, but results from a C+D survey say it can’t happen soon enough for some...

Christie and Co Annual Market Review 2024 - Listen

 • comment

C+D’s Managing editor clinical and custom content Nana Ofori-Atta sat down with the team at specialist broker Christie & Co for an update on the pharmacy market this year in this exclusive podcast. 

More from Analysis

Tackling unmet needs in women’s menstrual health

The launch of Maxwellia’s Evana® tranexamic acid Pharmacy-only medicine offers women greater access to treatment for heavy menstrual bleeding (HMB).

Premium Ingredients Are The Right Investment In Patient Health

With so many supplements on the market, claiming various health benefits, how do we pick out the key ‘big ticket’ formulas that are efficacious, deliver the best value for money, and ultimately make a positive difference to someone’s physiology?

Reddy, set, go!

There’s good news for seasonal rhinitis suffers as Dr. Reddy’s launches its new 120 mg Fexofenadine brand Histallay into the UK market in time for hayfever season...